Aspen has concluded a voluntary licensing agreement with MSD to develop, manufacture and commercialise alimatravir, a monthly oral dose of medicine used for the prevention of HIV-1.
Aspen has concluded a voluntary licensing agreement with MSD to develop, manufacture and commercialise alimatravir, a monthly oral dose of medicine used for the prevention of HIV-1.
Our career opportunities are across the corporate spectrum, including Human Capital, Digital Technology, Legal, and Risk & Sustainability. Our employees are given the opportunity to hone their skills and develop the experience of excellence in their chosen field in the pharmaceutical industry.